Bovine granulocyte chemotactic protein-2 is secreted by the endometrium in response to interferon-tau (IFN-τ)
- 94 Downloads
Interferon-tau (IFN-τ) is secreted by the bovine conceptus and may regulate synthesis of uterine endometrial cytokines to provide an environment that is conducive to embryo development and implantation. Interferon-τ stimulates secretion of an 8-kDa uterine protein (P8) in the cow. P8 was purified, digested to yield internal peptides, and partially sequenced to determine identity. Two internal peptides had 100% (13-mer) and 92% (12-mer) amino acid sequence identity with bovine granulocyte chemotactic protein-2 (bGCP-2). Bovine GCP-2 is an α-chemokine that acts primarily as a potent chemoattractant for granulocyte cells of the immune system. A peptide was synthesized based on a region of bGCP-2 that overlapped with a P8 peptide amino acid sequence, coupled to keyhole limpet hemocyanin, and used to generate high titer polyclonal antiserum in sheep. Western blots revealed that bGCP-2 was not released by endometrium from day 14 nonpregnant cows, but was released in response to 25 nM IFN-τ (p<0.05). Uterine GCP-2 exhibited high affinity to heparin agarose, a characteristic shared by all α chemokines. This is the first report describing presence of GCP-2 in the uterine endometrium and regulation by IFN-τ. The regulation of bGCP-2 by IFN-τ may have important implications for cytokine networking in the uterus during pregnancy. Also, the regulation of inflammation and angiogenesis by bGCP-2 working together with other cytokines may be integral to establishing early pregnancy and implantation in the cow.
Key WordsChemokine granulocyte chemotactic protein interferon pregnancy uterus
Unable to display preview. Download preview PDF.
- 1.Roberts, R. M., Godkin, J. D., Bazer, F. W., Fincher, K. B., Thatcher, W. W., Knickerbocker, J. J., and Bartol, F. F. (1985). In:Implantation of the Human Embryo. Edwards, K. G., Purdy, J., and Steptoe, P. J. (eds.). Academic, London, pp. 253–282.Google Scholar
- 2.Hansen, P. J. (1995).J. Reprod. Fertil. (Suppl.)46, 69–82.Google Scholar
- 5.Robertson, S. A., Semark, R. F., Guilbert, L. J., and Wegmann, T. G. (1994).Critical Rev. Immunol. 14, 239–292.Google Scholar
- 6.Roberts, R. M., Malathy, P.-V., Hansen, T. R., Fann, C. E., and Imakawa, K. (1990).J. Anim. Sci. 68, 28–38.Google Scholar
- 7.Thatcher, W. W., Meyer, M. D., and Danet-Desnoyers, G. (1995).J. Reprod. Fertil. 49, 15–28.Google Scholar
- 9.Roitt, I., Brostoff, J., and Male, D. (1989).Immunology, 2nd ed. Gower Medical, London, England.Google Scholar
- 10.Rueda, B. R., Naivar, K. A., George, E. M., Austin, K. J., Francis, H., and Hansen, T. R. (1993).J. Interferon Res. 13, 295–301.Google Scholar
- 13.Oppenheim, J. J., Zachariae, C. O. C., Mukaida, N., and Matsushima, K. (1991).Ann. Rev. Immunol. 9, 617–648.Google Scholar
- 15.Proost, P., Wuyts, A., Conings, R., Lenaerts, J. P., Billiau, A., Opdenakker, G., and Vandamme, J. V. (1993).Biochem. 32, 10,170–10,177.Google Scholar
- 22.Valente, A. J., Rozek, M. M., Sprague, E. A., and Schwartz, C. J. (1992).Circulation 86, 11,120–11,125.Google Scholar
- 23.Goldstein, I. M. (1992). In:Inflammation: Basic Principles and Clinical Correlates. 2nd ed., Gallin, J. I., Goldstein, I. M., and Snyderman, R. (eds.). Raven, New York, pp. 5574.Google Scholar